Literature DB >> 19233996

Evaluation of adverse drug reactions reported to a poison control center between 2000 and 2007.

Zdravko P Vassilev1, Alvin F Chu, Bruce Ruck, Edgar H Adams, Steven M Marcus.   

Abstract

PURPOSE: The likelihood of hospitalization caused by adverse drug reactions (ADRs) from commonly implicated therapeutic groups is discussed.
METHODS: A retrospective analysis of the computerized records of exposure cases involving pharmaceutical substances reported to the New Jersey Poison Information and Education System (NJPIES) was conducted from 2000 through 2007. The cases in the National Poisoning Data System that were categorized as an ADR were included in the study set. Only reports involving a single drug were selected for inclusion in the analyses. Characteristics of the ADRs, such as the sex and age of the patient, the therapeutic group involved, and the medical outcome of the exposure, were examined. Reports of ADRs with the most frequently implicated therapeutic groups were analyzed based on whether the patients were managed onsite, referred to a health care facility, or managed at a health care facility. The Adverse Drug Reaction Hospitalization (ADRH) index was calculated for all therapeutic groups, but the focus of the analyses was on the groups that were implicated in 5% or more of all ADRs.
RESULTS: A total of 454,520 cases of human poisoning exposure were reported to NJPIES from 2000 through 2007. Of these cases, 162,105 were exposures implicating a single drug, of which 5,461 (3.4%) were classified as an ADR. Of the 5,461 cases, 385 patients were admitted into a health care facility. Antidepressants had the highest ADRH index (20.4%) among the therapeutic groups implicated, and antimicrobials had the lowest (2.2%).
CONCLUSION: The analyses revealed a substantial variation in the likelihood of hospitalization associated with ADRs within different therapeutic groups. Among the groups that were most frequently implicated in ADRs, antidepressants showed the highest probability for an ADR-related hospitalization, followed by dietary supplements, herbals, and homeopathics and then by sedatives, hypnotics, and antipsychotics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19233996     DOI: 10.2146/ajhp080267

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  6 in total

1.  Non-health Care Facility Medication Errors Associated with Hormones and Hormone Antagonists in the United States.

Authors:  Pranav Magal; Henry A Spiller; Marcel J Casavant; Thitphalak Chounthirath; Nichole L Hodges; Gary A Smith
Journal:  J Med Toxicol       Date:  2017-09-13

2.  Antidepressant use and risk of adverse outcomes in older people: population based cohort study.

Authors:  Carol Coupland; Paula Dhiman; Richard Morriss; Antony Arthur; Garry Barton; Julia Hippisley-Cox
Journal:  BMJ       Date:  2011-08-02

3.  A two-year utilization of the pharmacist-operated drug information center in Iran.

Authors:  Taher Entezari-Maleki; Mohammad Taraz; Mohammad Reza Javadi; Mir Hamed Hajimiri; Kaveh Eslami; Iman Karimzadeh; Maysam Esmaeili; Kheirollah Gholami
Journal:  J Res Pharm Pract       Date:  2014-10

4.  Potentially high-risk medication categories and unplanned hospitalizations: a case-time-control study.

Authors:  Chih-Wan Lin; Yu-Wen Wen; Liang-Kung Chen; Fei-Yuan Hsiao
Journal:  Sci Rep       Date:  2017-01-23       Impact factor: 4.379

5.  Adverse drug reactions reported to the drug and poison information center of Tehran, Iran.

Authors:  Fatemeh Saheb Sharif-Askari; Narjes Saheb Sharif-Askari; Mohammadreza Javadi; Kheirollah Gholami
Journal:  PLoS One       Date:  2017-09-26       Impact factor: 3.240

6.  Retrospective assessment of acute poisoning incidents by nonpharmaceutical agents in Jordan: Data from Pharmacy One™ Poison Call Center, 2014 to 2018-Part I.

Authors:  Dima Albals; Alaa Yehya; Reem Issa; Aida Fawadleh
Journal:  Pharmacol Res Perspect       Date:  2020-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.